Roche Holding AG (RHHBY)
54.96
-0.26
(-0.46%)
USD |
OTCM |
Sep 04, 16:00
Roche SG&A Expense (TTM) : 29.37B for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 29.37B |
| December 31, 2025 | 28.59B |
| June 30, 2025 | 21.94B |
| December 31, 2024 | 16.93B |
| June 30, 2024 | 16.77B |
| December 31, 2023 | 16.58B |
| June 30, 2023 | 14.48B |
| December 31, 2022 | 13.11B |
| June 30, 2022 | 14.07B |
| December 31, 2021 | 14.48B |
| June 30, 2021 | 14.24B |
| December 31, 2020 | 13.49B |
| June 30, 2020 | 14.86B |
| December 31, 2019 | 15.19B |
| June 30, 2019 | 15.48B |
| December 31, 2018 | 15.45B |
| June 30, 2018 | 14.06B |
| December 31, 2017 | 13.21B |
| June 30, 2017 | 11.06B |
| December 31, 2016 | 10.69B |
| June 30, 2016 | 11.06B |
| December 31, 2015 | 11.66B |
| June 30, 2015 | 12.59B |
| December 31, 2014 | 13.06B |
| June 30, 2014 | 12.37B |
| Date | Value |
|---|---|
| December 31, 2013 | 11.59B |
| June 30, 2013 | 10.99B |
| December 31, 2012 | 12.14B |
| June 30, 2012 | 12.51B |
| December 31, 2011 | 11.73B |
| June 30, 2011 | 12.48B |
| December 31, 2010 | 11.93B |
| June 30, 2010 | 10.87B |
| December 31, 2009 | 10.76B |
| June 30, 2009 | 10.32B |
| December 31, 2008 | 10.62B |
| June 30, 2008 | 5.199B |
| December 31, 2007 | 7.483B |
| June 30, 2007 | 7.483B |
| December 31, 2006 | 0.00 |
| June 30, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| June 30, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
| June 30, 2004 | 0.00 |
| December 31, 2003 | 0.00 |
| June 30, 2003 | 0.00 |
| December 31, 2002 | 0.00 |
| June 30, 2002 | 0.00 |
| December 31, 2001 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Novartis AG | 13.14B |
| Eli Lilly & Co. | 12.24B |
| Merck & Co., Inc. | 11.14B |
| AstraZeneca PLC | 585.31M |
| Pfizer Inc. | 13.72B |